Screening of Small Non-coding RNAs as an Auxiliary Diagnostic Biomarker for Gastric Cancer
Launched by AFFILIATED HOSPITAL OF NANTONG UNIVERSITY · Jan 10, 2025
Trial Information
Current as of June 26, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
Gastric cancer is one of the most common malignancies of the gastrointestinal system, especially in East Asia. A host of patients are diagnosed with GC at the late stage, leading to poor patient prognosis. Therefore, there is a strong demand to develop new biomarkers to detect this tumor early.
Small non-coding RNA species include microRNA (miRNA), PIWI-interacting RNA (piRNA), small interfering RNA (siRNA), tRNA-derived small RNA (tsRNA), etc. It has been demonstrated by previous scientific researches that small non-coding RNAs are involved in gastric cancer cell proliferation, metastasis...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Having signed informed consent
- • Age≥ 18 years old and ≤ 85 years old
- • Histologically confirmed gastric cancer
- Exclusion Criteria:
- • Other previous malignancy within 5 year
- • Surgery (excluding diagnostic biopsy) within 4 weeks prior to study
- • Pregnancy or lactation period
- • Legal incapacity
About Affiliated Hospital Of Nantong University
The Affiliated Hospital of Nantong University is a leading medical institution dedicated to advancing healthcare through innovative research and clinical excellence. As a prominent sponsor of clinical trials, the hospital is committed to enhancing patient care by conducting rigorous studies that align with ethical standards and regulatory requirements. With a strong emphasis on collaboration among multidisciplinary teams, the hospital leverages its state-of-the-art facilities and expert staff to foster groundbreaking research initiatives aimed at improving treatment outcomes and addressing critical health challenges.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Nantong, Jiangsu, China
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported